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What is already known about the topic?
•• Domiciliary non-invasive ventilation may aid survival in chronic obstructive pulmonary disease, but evidence pertaining to 
improvement in quality of life is inconsistent and could be a barrier to use in palliative care.
What this paper adds?
•• Recommendations to optimise adaptation that emerged from our data include multi-modal education about non-invasive 
ventilation and community involvement in non-invasive ventilation care delivery.
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Abstract
Background: Domiciliary non-invasive ventilation may be used in palliative care of patients with chronic obstructive pulmonary 
disease, although there is uncertainty regarding effect on quality of life.
Aim: Explore experiences of domiciliary non-invasive ventilation in chronic obstructive pulmonary disease, to understand decision-
making processes and improve future palliative care.
Design: Qualitative interview study, based on constructivist grounded theory, and using the framework method for data management 
and analysis.
Participants: 20 chronic obstructive pulmonary disease patients, 4 carers and 15 healthcare professionals.
Results: Most patients had very severe chronic obstructive pulmonary disease. Data were categorised into four domains – clinical, 
technical, socio-economic and experiential. Healthcare professionals felt uncertain regarding clinical evidence, emphasising social 
support and tolerance as deciding factors in non-invasive ventilation use. Conversely, patients reported symptomatic benefit, which 
generally outweighed negative experiences and led to continued use. Healthcare professionals felt that patients chose to be on 
non-invasive ventilation; however, most patients felt that they had no choice as healthcare professionals recommended non-invasive 
ventilation or their poor health mandated it.
Conclusions: Our study identifies ‘adapting to non-invasive ventilation’ as the central process enabling long-term use in palliative 
care, although the way in which this is approached by healthcare professionals and patients does not always converge. We present 
ideas emerging from the data on potential interventions to improve patient experience and adaptation.
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Introduction
Non-invasive ventilation (NIV) is used to treat type 2 res-
piratory failure and can be used acutely in hospital,1 where 
it has clear benefits, or at home, where use is increasing as 
NIV machines have become cheaper and easier to use2 but 
the case for use is less clear. In chronic domiciliary use for 
chronic obstructive pulmonary disease (COPD), some 
studies have shown benefits on mortality3,4 and admission 
rate,5 but this is not consistent. A recent Cochrane review 
showed no significant difference in quality of life (QOL) 
when used in such patients, and few other clinically sig-
nificant benefits.6
In the United Kingdom, 11% of hospitalised COPD 
patients require NIV acutely;7 some may be unable to wean 
from NIV and thus require domiciliary use.8,9 Domiciliary 
NIV may also be started to prevent recurrent admissions,9 
or in palliative care of patients with chronic respiratory fail-
ure.10 Palliative care for COPD is a recognised area of 
unmet need,11 and very few qualitative studies exploring 
treatments used at this stage have been conducted. One of 
the larger NIV trials demonstrated improved short-term 
survival but decreased QOL;12 this could occur because 
NIV is seen as inconvenient, uncomfortable or noisy. Given 
the inconsistent evidence from questionnaires used in trials, 
we chose a qualitative study design, aiming to examine the 
processes and experiences surrounding starting and manag-
ing NIV from the perspective of healthcare professionals 
(HCPs) and COPD patients with a view to designing future 
services capable of aiding patient tolerance/adherence and 
reducing any impairment in QOL.
Methods
Study design and ethical considerations
A qualitative interview study, approved by local ethics com-
mittee (11/WM/0422), was conducted over a 4-month period 
in 2012. Written informed consent was taken from partici-
pants; 1 of 22 patients approached refused to consent, and 
none withdrew consent. One patient was excluded as their 
treatment was found to be CPAP and not NIV. The remaining 
participants were HCPs or carers of the patients.
Recruitment and sampling
Participants were recruited using purposive sampling. We 
aimed to conduct 30 interviews, as prior experience has 
shown this sufficient to gain meaningful insights in 
applied qualitative health research, but this was later 
expanded to address emerging themes in the data. Patients 
were identified by clinical teams. Inclusion criteria were 
as follows: COPD, past or current use of domiciliary NIV 
or at least two episodes of acute NIV use. The latter group 
was chosen as potential future domiciliary NIV users.13 
Exclusion criteria included clinical instability or lack of 
mental capacity. All patients were told they could invite a 
carer to be interviewed; this was done to gain perspective 
on the contributions of carers to delivery of NIV and 
ascertain whether patients felt their carers’ input was nec-
essary to continue use. HCPs were recruited if they had 
experience of initiating or managing acute or domiciliary 
NIV in COPD patients. The interviewer (M.J.), a female 
medical student, was not known to participants prior to 
the study, had qualitative interview technique training as 
part of her research degree and was mentored by N.K.G. 
and A.M.T. during the process.
Data collection
Audio-recorded, face-to-face qualitative interviews were 
conducted in the interviewees’ preferred location (patients’/
carers’ homes or at a hospital) by M.J. Interview schedules 
were prepared in advance by M.J., N.K.G. (medical soci-
ologist) and A.M.T. (consultant respiratory physician), 
covering general views on NIV, decision-making pro-
cesses to commence domiciliary NIV and experiences of 
long-term NIV use (supplementary data). Field notes were 
taken during interviews to aid subsequent interpretation.
All patients also consented to data collection from their 
hospital records. This was done to improve transferabil-
ity14 of findings and gauge the typicality of participants. 
Direct questioning established MRC dyspnoea and Lawton 
Instrumental Activities of Daily living scores.15 No follow-
up interviews were conducted and there was no participant 
input to transcription/correction of recordings.
Analysis
Interviews were transcribed verbatim and analysed 
descriptively using conventional (inductive) qualitative 
content analysis16 (Figure 1). Open coding was applied to 
transcripts, line-by-line, independently by both N.K.G. 
and M.J. without the aid of qualitative data analysis soft-
ware. Inductive codes were created for patient interviews 
while both inductive and deductive codes were used to 
analyse HCP interviews. A descriptive coding framework 
was developed and agreed; concepts were grouped and 
summarised in a matrix using the framework method.17 
Descriptive themes were developed from the data and 
Implications for practice, theory or policy
•• Service designs that better facilitate adaptation through education and practical support could aid use of domiciliary non-
invasive ventilation in palliative care.
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Figure 1. Coding framework used in data analysis.
deviant cases identified. Subsequent interpretive thematic 
analysis, based on constructivist grounded theory, was 
conducted focusing on ‘social actions’.18 The central sub-
stantive theory that was developed and is described herein 
was ‘adapting to domiciliary NIV’. Key findings are 
reported with illustrative quotes using anonymous identi-
fiers: HCPs [HCP#], patients [P#] and carers [C#].
The above codes were used during analysis of patient 
(and carer) transcripts and HCPs, respectively. Several types 
were used including ‘in-vivo’, attribute, emotions, values, 
description or magnitude codes, the aim being to highlight a 
range of issues identified in the transcripts, allow meanings 
to develop and to be attached to the data. From these, the 
major and minor themes listed in Table 2 emerged.
Results
Participant characteristics
In all, 39 participants were recruited from two hospitals in 
Birmingham, UK. Characteristics of the patients (n = 20) 
are shown in Table 1; 12 were chronic users of home NIV, 
3 past users and 5 recurrent acute users. Patients had very 
severe symptomatic COPD, a high burden of COPD-
related co-morbidities and high disability scores. Two past 
users stopped due to intolerance, one due to receipt of a 
lung transplant. The data concurred with the literature 
showing the negative impact of COPD on patients’ lives.19 
Five patients lived alone with no daily carer; four had cur-
rent daily carers (three spouses and one sibling) who 
agreed to interview; no other carers were willing/able to be 
interviewed. Carers were similar in age to patients, were 
generally well with few active health problems and no sig-
nificant disability and shared patients’ views of COPD. All 
patients and carers were White British or Irish.
The 15 HCPs recruited comprised 7 doctors, 4 special-
ist nurses, 2 physiotherapists and 2 physiologists. HCPs 
were aged 26–54 years and were predominantly UK born 
and educated, with a range of ethnicities. There were no 
notable differences in the themes emerging from different 
HCP types. Interview duration averaged 40 min (range 
19–68 min).
Negotiating domiciliary NIV use
Decisions regarding domiciliary NIV were reportedly 
based on unclear clinical evidence, influenced by past 
experiences and individual negotiations. The social actions 
undertaken to assess whether a patient was offered domi-
ciliary NIV and was likely to ‘comply’, as well as actions 
4 Palliative Medicine 
that patients took to decide whether they accepted and con-
tinued it have been categorised into four themes: clinical, 
technical, socio-economic and experiential. Table 2 pro-
vides a list of social actions (gerunds) identified in the 
analysis, grouped thematically, and provides illustrative 
quotes. It demonstrates clearly where views and experi-
ences of HCPs and patients contrasted. Table 3 shows 
areas that emerged from the analysis that could be the 
focus of future care redesign. All themes contributed to the 
evidence pertaining to patient selection; technical and 
experiential themes were informative regarding mecha-
nisms to improve tolerance/adherence and the socio-
economic theme informed suggestions about health service 
designs supporting NIV use.
Clinical domain
The focus for HCPs was addressing clinical indications 
and improving outcomes. They felt limited by the absence 
of clear evidence on measurable benefits (e.g. hospital 
admissions, mortality), thus selected for treatment on a 
case-by-case basis. They described the importance of 
taking time to convey the purpose of NIV to patients, to 
promote patient choice and to support compliance. HCPs 
tended to stress that the decision was ultimately the 
patients’; conversely, patients felt they had no choice about 
whether or not to accept domiciliary NIV, relying on their 
doctors’ recommendations, believing they would act in 
their best interests. Nevertheless, many patients linked 
their acceptance of NIV with wanting to extend life and 
improve QOL.
QOL. HCPs acknowledged that they struggled with the 
potential for NIV to impair QOL and balancing this with 
uncertainty of clinical effectiveness:
If someone is really terminal COPD are you really going to do 
them any good by sticking them on a machine which might 
make their quality of life worse and they will probably die 
anyway whether you give them NIV or not. So the patient 
selection should be looked at very well before we start it on 
everyone [HCP #12].
Patients, however, were almost unanimous in their view 
that QOL improved with the use of home NIV, stating ‘it 
has given me quality of life’ [Pt #8]; ‘It’s done me proud’ 
[Pt #1]; ‘It’s done me the world of good’ [Pt #6]; ‘It might 
be because of this machine I haven’t been so ill’ [Pt #10] 
and ‘It has helped me and I am grateful of it’ [Pt #19]. One 
patient was convinced that NIV was the reason she was 
alive; ‘it was beneficial to me; it kept me going for 
10 years … that was quite an achievement’ [Pt #1]. Many 
patients while acknowledging the medical purpose of 
NIV, to ‘get the carbon dioxide out of the system’ [Pt #10] 
and ‘open up all the airways’ [Pt #17], were also able to 
delineate specific symptomatic benefits. Patients experi-
enced improvements in breathlessness, ‘it helps me 
breath’ [Pt #8] and in their general well-being, ‘gives me 
a bit more energy’ [Pt #1]. Patients also conveyed that 
NIV was helping them carry out their activities of daily 
living ‘to do more’ and ‘get around more’ [Pt #10]. 
Ultimately, this helped them to ‘give me back a normal 
life … to get me back to a normal existence’ [Pt #1]. 
Carers also shared the same thoughts, revealing how they 
thought again it was ‘a God-send’ [C #8].
Socio-economic domain
Challenges of maintaining equitable care due to social 
deprivation were raised (e.g. failure to engage due to trans-
port costs) as well as the potential for primary care involve-
ment to improve management (Table 2). Some did not 
focus on equity, but felt it important to ensure that resources 
were not wasted. Generally, HCPs considered it cost-effec-
tive. People with COPD acknowledged their dependence 
on family and friends. They valued high-quality informa-
tion and support and were critical where gaps were left. A 
Table 1. Characteristics of patient population.
Characteristic Count (%) or median (range)
Male:female 8 (40):12 (60)
Age (years) 68 (52–83)
BMI 28.5 (17.9–47.0)
Years since diagnosis 8 (4–20)
% Predicted FEV1 27 (18–66)
Pack years smoked 63 (4.3–132)
PaO2 (kPa) 7.48 (6.49–10.8)
PaCO2 (kPa) 7.17 (5.51–11.4)
NIV
 Months of use 17 (0.2–140)
 Hours/day 7 (2–24)
 IPAP 18 (12–25)
 EPAP 5.5 (4–9)
 Nocturnal use only 15 (75)
 Full face mask 19 (95)
 Nasal mask 1 (5)
LTOT 15 (75)
Number of daily carers 1.5 (0–7)
COPD-related co-morbidities
 0 1 (5)
 1 7 (35)
 ⩾2 12 (60)
Lawton IADL 4.5 (1–8)
MRC score 4.5 (1–5)
BMI: body mass index; NIV: non-invasive ventilation; LTOT: long-term 
oxygen therapy; COPD: chronic obstructive pulmonary disease.
All data are shown as median (range) except gender, day/night NIV 
use, LTOT and COPD-related co-morbidities which are shown as n 
(%). Blood gas values are from the outpatient setting, while using NIV/
LTOT in their usual manner (if applicable).
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few patients acknowledged financial restrictions, citing 
feelings of guilt when they had to ask for replacement 
masks, but resisted if perceived unfair.
Role of carers and the home environment. For HCPs assess-
ing the patients’ social situation was crucial; poor support 
led to concerns regarding NIV compliance and therefore 
subsequent efficacy. They assessed whether ‘the home set 
up is appropriate for it [NIV]’ [HCP #2] as those with ‘very 
supportive family sometimes I think they have the best 
outcome’ [HCP #5].
Adaptation to NIV was not an individual experience, 
but extended beyond to patient’s families. Patients devel-
oped an increased reliance on their family for many aspects 
of their lives due to their disability, such as requiring assis-
tance for routine self-care such as bathing or getting to 
hospital appointments. The patient’s family also became 
the first port of call for any NIV-related problems, which 
patients saw as a burden; ‘Poor husband has been up and 
down the hospital I don’t know how many times … I told 
him to go up and get another one and he got it and that 
wasn’t right the poor bloke was traumatised’ [Pt #3]. 
‘There was something wrong with my mask I can’t remem-
ber what it was and my son had to take it in’ [Pt #1]. Carers 
generally exhibited similar attitudes towards NIV as their 
partner/sibling; ‘we just got used to it … something you’ve 
got to put up with’ [C #14] again accepting NIV because of 
the perceived idea that it is essential; ‘she does really need 
it’ [C #3].
There were no major differences observed in adaptation 
processes or patterns between patients with and without 
carers. Some patients who lived alone felt NIV impaired 
their ability to form intimate relationships ‘You could 
never have a partner’ [Pt #10]; this was acknowledged by 
one who commented on the way the NIV disturbed his 
wife’s sleep (Table 2).
Technical
Patients and HCPs explained that NIV caused a number 
of problems. The mask was painful and caused facial 
sores. Dryness in the mouth and skin, noise and claustro-
phobia were also widely reported. However, patients 
described feeling that they had to adapt to discomfort, by 
way of numerous (often partial) technical fixes, such as 
using moisturiser or plasters on pressure points, along-
side accepting discomfort because they ‘had to’. This 
notion of forced adaptation to NIV links to the patients’ 
view that they had no choice over whether to use it. 
HCPs’ accounts emphasised ways in which patients could 
contact the service for support, rather than day-to-day 
coping mechanisms.
Experiential
This domain was recognised as vital by both HCPs and 
patients because it was a determinant of long-term NIV 
use. The perception of whether NIV was improving QOL, 
brought symptomatic relief and improved or disturbed 
sleep was important. There were two deviant cases; one 
patient exclaimed how he ‘hates it’ and that it should be 
given ‘to people in prison, they won’t go back again’ [Pt 
#12], yet this patient still continues to use it. Another 
patient who had only used NIV at hospital declared that ‘if 
the King came to me and said you gotta have one, I’d say 
no’ [Pt #20].
Personality was cited by HCPs (ability to cope, accept-
ance), patients and carers (strength, a positive attitude to 
life) as an important determinant of success with NIV. 
Sufficient time to adapt to the treatment was noted to be 
important, but was highly variable – it ranged from ‘a cou-
ple of minutes’ [Pt #17] for some patients, up to ‘months’ [Pt 
#11] for others. The risk of patients becoming dependent, 
Table 3. Emerging themes to aid initiation and adaptation to domiciliary NIV in COPD.
HCPs Patients/carers
Clinical Clarity regarding clinical effectiveness Understanding physical effects and potential 
clinical benefit of NIV
 Use of multi-modal education – verbal, 
written and audio-visual
Balancing against risk of not having NIV
Socio-economic Data on cost–effectiveness Flexibility to reduce hospital visits by use of 
outreach or posting of equipment
 Involvement of community teams in NIV 
delivery and maintenance
Assistance with financial elements – such as 
how to claim electricity costs
Technical Flexibility in changing masks Guidance on skin protection
 Humidification Guidance on ways to avoid dry mouth
 Easy access to support services Help for their partners’ sleep
Experiential Teaching about NIV outside the acute 
setting
Cognitive-behavioural therapy to aid 
understanding of emotional reactions
 Honesty on limitations of NIV  
NIV: non-invasive ventilation; COPD: chronic obstructive pulmonary disease; HCP: healthcare professional.
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clinically or emotionally, was acknowledged by all groups 
(Table 2).
Discussion
Our data demonstrate that starting and continuing domi-
ciliary NIV requires active negotiation by patients and 
HCPs and is informed by clinical, socio-economic, techni-
cal and experiential forms of ‘evidence’. Improved under-
standing and a critical perspective on these could lead to 
more effectively targeted interventions to reduce any nega-
tive effects on QOL.
Clinical issues, including QOL and patient 
choice
The most important element for both patients and HCPs 
was whether domiciliary NIV was clinically effective, and 
what the risks were if not used. Individual clinicians may 
choose to weigh the clinical evidence up differently. In one 
large trial, 144 severe COPD patients were randomised to 
long-term oxygen therapy (LTOT) with or without NIV; 
patients on NIV were more likely to survive (hazard ratio 
(HR) 0.63 (0.40–0.99)); however, this was at the expense 
of QOL (p = 0.002).12 A more recent study has confirmed 
this survival benefit.4 Conversely, slight improvements in 
disease-specific QOL have been reported20,21 as have lower 
admission rates.5,21 Differences in outcome may have 
resulted from use of different tools to assess QOL – the 
36-Item Short-Form Health survey (SF-36),12 St Georges 
Respiratory Questionnaire (SGRQ)20 and Maugeri 
Foundation Respiratory Failure Questionnaire (MRF-28), 
respectively;20 arguably the latter might be more informa-
tive in this highly selected population. Differing NIV pro-
tocols may also be relevant; higher pressures may result in 
more impressive changes in blood gases and lung function, 
alongside improved QOL.10 This implies that lack of clini-
cal effect in some studies could simply be due to a subop-
timal protocol.
Patients usually described symptomatic relief and 
improved daily function on NIV, outcomes not reported 
widely in previous domiciliary NIV trials. Primary out-
comes in the largest two trials were severity of hypercap-
nia21 and survival,12 demonstrating HCPs’ perception that 
use of domiciliary NIV should provide measurable clinical 
improvements rather than ‘softer’ symptomatic outcomes. 
Early work has now been carried out, albeit in a different 
population, to assess the feasibility of NIV for palliative 
care and has shown promise.22 This, together with our 
data, suggests that negativity regarding prior QOL data 
should be balanced against the potential for this treatment 
to improve lives.
Honesty about the potential risk and benefits of treat-
ment was perceived as vital before prescribing domiciliary 
NIV. In most of the accounts, death and its potential 
proximity were starkly absent, suggesting that discussions 
about palliative care were limited. Evidence across other 
chronic diseases suggests that patients value HCPs obtain-
ing their opinion on end-of-life care, although many prefer 
clinicians to make the final decisions.23 This applies par-
ticularly to older patients with poorer health or a lower 
socio-economic status,24 as many of our group were.
Any medical ‘choice’ a patient makes is limited to the 
opportunities presented by HCPs unless they actively seek 
alternatives. Patient choice is an important value25 cited by 
HCPs, but COPD patients’ accounts show that choices 
were highly constrained – indeed, many felt NIV was their 
only option to survive. To manage this lack of choice, 
patients explained that they trusted their doctors and were 
committed to extending their lives, even if that required 
adaptation to the physical and psychological side effects of 
NIV. This is an example of forced adaptation.
Socio-economic issues, including the role of 
carers
Health economics was a factor recognised by patients and 
HCPs; it may be cost-effective in those with recurrent hos-
pital admissions.13 HCPs described situations where 
because of a perceived inability to cope, personality type 
or poor social support, they would not offer patients NIV, 
implying an inherent risk of inequality in terms of who is 
offered NIV. Despite this, it was apparent that many 
patients with no close social support received NIV in our 
study. Carer involvement has been found essential in 
patients using NIV for neuromuscular disease,26 although 
differences in physical ability to put the machine could 
reduce the generalisability of this evidence to COPD. 
Where carers were present, they played a major role in 
NIV care delivery; however, this is an area in which exter-
nal care might be provided, as acknowledged by inter-
viewed HCPs (Table 2). Inequity might be avoided if 
greater systemic adaptations to domiciliary NIV were 
instituted (Table 3).
Technical issues and adaptive solutions
The necessity to ‘get used to’ NIV was a central theme. 
HCPs offered a range of solutions to improve tolerance: 
technical suggestions about the equipment, educational 
solutions to improve motivation and radical social changes, 
such as moving someone to a care home to improve carer 
support. Patient accounts stressed their acceptance of the 
need to adapt, even with substantial discomfort or anxiety. 
The latter may have implications for setting up of NIV, 
which is often done in hospital.27
The process of adaptation appeared central for contin-
ued NIV use. An important tension was that whereas HCPs 
stressed access to support, patients often felt the burden of 
adaptation was theirs and did not discuss issues with their 
5
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HCPs. Simple measures like leaflets outlining technical 
solutions may be insufficient – these were often reported 
by HCPs but rarely remembered by patients. DVDs, video 
demonstrations posted online or patient-led workshops 
might be useful alternatives. Ongoing investment in 
machine or mask comfort will no doubt also help. Despite 
tolerance issues, our data concurred with previous studies 
in showing high levels of acceptance of domiciliary NIV 
by COPD patients.28
Experiential issues
Perceptions of usefulness, especially in terms of improved 
ability to perform the activities of daily living and symp-
tom relief, were important in decision-making, even where 
clinical explanations for these effects were unclear. These 
wider types of evidence may be key to managing end-stage 
COPD, where ‘cure’ is not achievable.
A number of patients reported bad experiences of acute 
NIV which influenced their opinion of domiciliary NIV 
and might be amenable to change. Education about NIV 
early in disease, so that it comes as less of a shock when 
admitted acutely, might help. Greater education of acute 
support staff could aid reassurance. Finally, the setting for 
starting domiciliary NIV might be changed – hospital 
commencement has strong support for technical aspects, 
but psycho-social support is poorer. Home commencement 
by community nurses could aid adaptation, particularly for 
fearful patients.
Strengths and limitations
The strength of this study was the range of perspectives 
collected, across HCP types and geographical areas (two 
hospitals). We reduced bias by obtaining lists of NIV 
patients from clinicians from which we purposively sam-
pled eligible participants. However, the sample lacked eth-
nic diversity; this was reflective of those on NIV but was 
not reflective of the local population. While we continued 
recruiting until we felt that no new issues were emerging in 
the data, we were not able to return after analysis to further 
explore themes. It, therefore, remains possible that satura-
tion was not achieved, and that the relative lack of number 
of carers could have biased findings pertinent to this sub-
group. It is important to note that this study was not an 
efficacy study of domiciliary NIV and should not be inter-
preted as such.
Conclusion
Both patients and HCPs actively negotiate the process of 
patients’ adaptation to NIV, although their experiences and 
views are not always convergent. Their actions can be 
understood within the context of clinical, socio-economic, 
technical and experiential factors. While domiciliary NIV 
is valued by COPD patients, the process of adaptation 
could be optimised by HCPs considering broader ways of 
explaining the process, other settings for initiation and 
generating more patient-centred data on its benefits.
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